Quick Answer
Bio Essence Corp reported Cash and Equivalents of $1.4 thousand for fiscal year 2024.
Bio Essence Corp Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2024 | $1.4K | +1102.6% |
| 2023 | $114.00 | -98.2% |
| 2022 | $6.3K | +1966.7% |
| 2021 | $303.00 | -94.3% |
| 2020 | $5.3K | -67.1% |
| 2019 | $16.2K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $28.7K | -3.6% | +1996.4% |
| December 31, 2024 | $1.4K | — | -95.4% |
| September 30, 2024 | $29.8K | +33403.4% | +129543.5% |
| March 31, 2024 | $23.00 | -81.9% | -74.2% |
| September 30, 2023 | $89.00 | -84.4% | -83.5% |
| June 30, 2023 | $541.00 | +347.1% | +326.0% |
| March 31, 2023 | $127.00 | -43.6% | -98.0% |
| December 31, 2022 | $6.3K | +1966.7% | +994.8% |
- Bio Essence Corp showed an increase of +1102.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2019–2024 period, Bio Essence Corp’s cash and equivalents has declined by 91.5% (from $16.2 thousand to $1.4 thousand).
- The most recent figure is from Bio Essence Corp’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 28, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: